Table 1 Correlation of GATA6 expression and patients’ clinicopathological variables in GC tissues
From: GATA6 suppresses migration and metastasis by regulating the miR-520b/CREB1 axis in gastric cancer
Variables | Expression of GATA6 | p-value | ||
---|---|---|---|---|
ALL cases (n = 77) | Low expression (n = 41) | High expression (n = 36) | ||
Age (years) | 0.613 | |||
≤50 | 21 | 10 | 11 | |
≥50 | 56 | 31 | 25 | |
Gender | 0.642 | |||
Male | 49 | 25 | 24 | |
Female | 28 | 16 | 12 | |
Tumor size (cm) | 0.174 | |||
≤5 | 34 | 15 | 19 | |
>5 | 43 | 26 | 17 | |
Grade of differentiation | 0.037 | |||
G1 | 6 | 4 | 2 | |
G2 | 33 | 12 | 21 | |
G3 | 38 | 25 | 13 | |
Tumor invasion | 0.014 | |||
T1 | 14 | 5 | 9 | |
T2 | 9 | 2 | 7 | |
T3 | 44 | 29 | 15 | |
T4a/b | 3 | 3 | 0 | |
Lymph node status | 0.008 | |||
N0 | 12 | 2 | 10 | |
N1 | 8 | 3 | 5 | |
N2 | 18 | 13 | 5 | |
N3a/b | 32 | 21 | 11 | |
Distant metastasis | 0.012 | |||
M0 | 57 | 25 | 32 | |
M1 | 13 | 11 | 2 |